The Emerging Pandemic of Coronavirus and the Urgent Need for Public Health Leadership - 19/06/20

Funding: None. |
|
Conflict of Interest: CHH discloses that that he serves as an independent scientist in an advisory role to investigators and sponsors as chair or member of data and safety monitoring boards for Amgen, British Heart Foundation, Cadila, Canadian Institutes of Health Research, DalCor, Lilly, Regeneron and the Wellcome Foundation, and to the US Food and Drug Administration and UpToDate; receives royalties for authorship or editorship of 3 textbooks and as co-inventor on patents for inflammatory markers and cardiovascular disease that are held by Brigham and Women's Hospital; has an investment management relationship with the West-Bacon Group within SunTrust Investment Services, which has discretionary investment authority and does not own any common or preferred stock in any pharmaceutical or medical device company. |
|
Authorship: All authors had access to the data and a role in writing this manuscript. |
Vol 133 - N° 6
P. 648-650 - juin 2020 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.